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Pain has been a major concern of humankind since the ancient times, and it
remains one of the most important subjects of all health care professionals.
Despite the obvious overwhelming clinical importance, the major advances in
its diagnosis and therapy have been made only recently.
"How do the sensory apparatus of the body and system of signal transmission
relate to pain of peripheral origin?" is the topic of discussion. To do this, it is
important to understand what constitutes the total pain experience. It consists
of: 1) signal transduction at the peripheral receptor site, 2) signal conduction
along the peripheral nerve, 3) pain modulation at the level ofthe spinal cord, 4)
pain perception at the supraspinal site, and 5) the associated sensations, emo-
tionalreactions, and affective state.
The signal transmission related to pain may be modified by various analgesic
agents. Specific analgesic agent has a specific site of action which may be at
peripheral receptors, at peripheral nerves, at the level of the spinal cord, at
supraspinal levels by activating descending inhibitory systems, or at more
cephalad levels by reducing the affective component ofpain.
PAIN PATHWAYS
Pain transduction at theperipheral receptors
Peripheral receptors for pain are naked, free nerve endings that spread out among
epidermal cells, and that for temperature are free nerve terminals, end-bulbs of Krause,
and Ruffini's corpuscles. These structures are affected by aspirin, acetaminophen, and
other nonsteroidal anti-inflammatory drugs used as analgesic agents. Although these
compounds represent diverse chemical entities, their common mechanism of action is
inhibition of prostaglandin-mediated amplification of chemical and mechanical irritants
on sensory pathways. The majority of these agents modulate prostaglandin synthesis
through inhibition of the action of the enzyme cyclo-oxygenase, which is one ofthe first
steps in the conversion of arachidonic acid into prostaglandins. By reducing
prostaglandin synthesis, cyclo-oxygenase inhibitors block the nociceptive response to
endogenous mediators ofinflammation, and theeffectis greatest in tissues that havebeen
subjected to trauma and inflammation. The actions of cyclo-oxygenase inhibition on
platelet function and vascular responses to inflammation may be undesirable, and under-
standing of these factors is important for the selection ofagent. Since all the compounds
in this group do not block cyclo-oxygenase, the membrane stabilization theory has been
postulated. Membrane stabilization could account for decreased prostaglandin release
seen at concentrations that are lower than those needed for effective cyclo-oxygenase
inhibition. Corticosteroids, tricyclic anti-depressants, and local anesthetics are also con-
sidered to possess membrane-stabilizing effects.
aTo whom allcorrespondence shouldbe addressed. Tel. (203) 785-2802; FAX: (203) 785-5572.
bAbbreviations used: WDR, wide dynamicrange.
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Signal conduction at theperipheral nerves
Nociceptive information is transmitted through the first-order neurons with small
diameter nerve fibers. The distal part of the axon brings nociceptive information from the
receptor toward the cell body, the ganglion cells of which are the cell bodies located in
the dorsal root ganglia. The central branch of the axon extends to the spinal cord at the
dorsal root entry zone. Pain and temperature are transmitted through A-delta fiber and C-
fiber. This transmission of nociceptive impulses can be blocked completely by the use of
local anesthetics [1,2].
Modulation at the spinal cord level
The dorsal horn of the spinal cord is the first site of modulating nociceptive informa-
tion arriving from periphery and reaching the central nervous system [3-5]. Melzack and
Wall [6] proposed a so-called gate control theory of pain in 1965 which has had major
historical significance but has been refuted in most, if not all, of its specific details. Wall
has updated the gate control theory several times to make it consonant with advancing
knowledge in the field. Unfortunately, he has continued to use the same name "gate con-
trol theory ofpain," for his updated versions. Significant modulation ofnociceptive input
through the dorsal horn of the spinal cord may be exerted by the use ofopioid analgesics
[7-18] and general anesthetics [19-24]. The better terminology to describe the basic
mechanism of this modulation could be "gain control" rather than "gate control" [25].
Another form ofmodulation is descending inhibition.
Descending inhibition
The concept of descending pain modulation was proposed during the early part of
this century by Sherrington [26], who emphasized that the interaction between excitatory
and inhibitory systems was crucial in the processing of sensory information from the
body structures to the brain. Hagbarth and Kerr [27] were the first to provide evidence
that corticospinal fibers influenced afferent transmission and the conduction at the spinal
levels. Descending systems from the brainstem to the dorsal horn of the spinal cord have
been implicated in the production of analgesia following electrostimulation ofperiacque-
ductal gray matter [28, 29] or microinjection of morphine into the brainstem nuclei
[30-32]. In addition, serotonergic and adrenergic systems play an important role in exert-
ing descending inhibition on the dorsal horn neurons, thereby producing analgesia
[33-35].
Methodological assessment techniques have improved considerably during the past
several years [36]. Utilizing the improved assessment techniques, many old concepts
have been re-examined. For instance, the belief that barbiturates are hyperalgesic or
antianalgesic has been held for the past three decades based on two clinical studies with-
out the benefits of basic scientific studies. Recently, Collins et al. [37] examined the
influence of pentobarbital on the descending inhibition utilizing a sophisticated neuro-
physiological technique. They have demonstrated reduction in tonic descending inhibi-
tion ofspinal dorsal hom neurons by barbiturate, supporting the three decade old concept
ofbarbiturate hyperalgesia.
Perception at thesupra spinal sites
Axons of second-order neurons have nerve cell bodies in the dorsal horn of the
spinal cord. The axons cross to the opposite side, and turn cranially to enter the lateral
spinothalamic tract and reach the medulla. Some fibers send collateral to the brainstem
reticular formation in the medulla and pons. In the mid-brain, this tract is located at the
posterolateral aspect of the medial lemniscus. Before these second-order neurons end in
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the specific thalamic nucleus, some fibers enter the reticular system. The nucleus reticu-
laris giganto-cellularis is one ofthose nuclei which receives terminal endings ofthe noci-
ceptive second-order neurons. This group ofspecific nociceptive neurons are profoundly
suppressed by general anesthetics andopioid analgesics [38-41].
TYPES OF PAIN
The experiences ofpain may be classified into four distinctive types and phases: 1)
processing of brief noxious information, 2) prolonged noxious stimulation secondary to
peripheral tissue damage and inflammation, 3) neuropathic pain and 4) sympathetically
maintainedpain.
Brief noxious processing is a result of brief noxious mechanical, chemical and/or
thermal stimulation of the peripheral receptors or peripheral nerves, more specifically A-
delta fibers. In the spinal ascending system, "the lateral system", including the spino-
thalamic tract is concerned with processing of brief noxious information. Phasic and
discriminative nociceptive information is transmitted rapidly through this system. Local
anesthetics can completely block theprocessing ofbriefnoxious information.
Prolonged noxious stimulation mainly through unmyelinated C fibers of the periph-
eral nerves is further transmitted in the spinal ascending system through "the medial sys-
tem", which includes spinoreticular and spinomesencephalic tracts. Tonic and nonde-
scriptive nociceptive information is transmitted slowly through this system. This type of
pain can be blocked with the use of local anesthetics, opioid analgesics and/or various
anti-inflammatory drugs.
Neuropathic pain occurs when persistent noxious C fiber barrage of peripheral
nerves causes sensitization ofcentral sensory neurons which results in "central hyperalge-
sia" [42]. Tricyclic antidepressant or anticonvulsant drugs have been shown to be effec-
tive in reducing this pain phenomenon. Prolonged state ofcentral hyperalgesia will result
in neuropathic pain which includes deafferentation pain [43]. Critical manifestations of
deafferentation pain as a result ofinjury orsurgical trauma are associated with the diverse
lesions in the nervous system. The role ofperipheral and central processes in deafferenta-
tion pain has been extensively studied in our laboratory [43]. The use oflocal anesthetics
to block axon conduction of the first-order neurons, or the use ofopiate analgesics in the
spinal neural axis, have been shown to play an important role in the new concept of "pre-
emptive analgesia" [44-46].
In addition to the somatic nervous system, the sympathetic nervous system plays an
important role in producing so called sympathetically maintained pain. Following trauma,
action potentials in nociceptive afferents propagate through the dorsal root ganglia to the
spinal cord, where they activate WDRb neurons whose axons are sent to higher centers.
The available data suggest that persistent sensitization of WDR neurons in the dorsal
horn of the spinal cord occurs as a result of the initial massive input from nociceptive
afferents that occurs at the time ofinjury. In this situation, low-threshold mechanorecep-
tive afferents activated by light tactile stimulation can provoke increased excitation ofthe
WDR neurons and thus produce allodynia. In turn, the low-threshold mechanoreceptor
afferents can be activated by the sympathetic efferent activity and thus produce sympa-
thetically maintained pain.
PAIN REACTION
Affective state and emotional reactions play a significant role in the perception of
pain. It is important to recognize the motivational and cognitive contributions to pain.
Psychologic approaches are known toproduce some measure ofpain relief.
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FUTURE PROSPECTS
It should include valid clinical studies on the subject ofpreemptive analgesia. There
has been considerable experimental evidence for the phenomenon ofcentral hyperalgesia
which could be prevented by blocking the peripheral nociceptive conduction with the use
of local anesthetics [42]. Clinical evidence has been accumulating which suggests that
certain analgesic techniques initiated prior to noxious surgical stimulation are capable of
reducing postoperative pain levels [44-46]. However, as Kehlet and Dahl [47] have
pointed out, good clinical studies to document the quantitative role ofcentral neuroplas-
ticity on the magnitude and duration ofthepain states are needed.
Pain has been a major concern of humankind since our beginnings. It has been the
object of ubiquitous efforts to understand and to control it. In the future, we must exert
greater efforts and expand greater energy to solve the mystery of pain and to carry out
more effective therapy. In order to achieve this goal, proper understanding ofpain path-
ways and transmission is essential. This will require that basic scientists mustjoin forces
with clinical scientists and clinicians to further elucidate the intimate nature of this most
vexing human problem.
SUMMARY
There is little question that pain is a sensation with special structural, functional, and.
perceptual properties. The total pain experience is the result of nociceptive signal trans-
duction at the peripheral receptors, nociceptive signal conduction along the peripheral
nerves, modulation at the spinal level, pain perception at the supraspinal sites, and emo-
tional reactions and associated sensations. Each analgesic agent has its own sites and
mechanisms ofaction. When one administers such drugs to provide pain relief, optimum
analgesia may be obtained by understanding the specific sites and mechanisms ofaction
ofeach drug.
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